These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 11992747)

  • 1. Update of ACR guidelines for osteoarthritis: role of the coxibs.
    Schnitzer TJ;
    J Pain Symptom Manage; 2002 Apr; 23(4 Suppl):S24-30; discussion S31-4. PubMed ID: 11992747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteoarthritis management: the role of cyclooxygenase-2-selective inhibitors.
    Schnitzer TJ
    Clin Ther; 2001 Mar; 23(3):313-326; discussion 311-2. PubMed ID: 11318071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee.
    Hochberg MC; Altman RD; April KT; Benkhalti M; Guyatt G; McGowan J; Towheed T; Welch V; Wells G; Tugwell P;
    Arthritis Care Res (Hoboken); 2012 Apr; 64(4):465-74. PubMed ID: 22563589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New directions in symptomatic therapy for patients with osteoarthritis and rheumatoid arthritis.
    Hochberg MC
    Semin Arthritis Rheum; 2002 Dec; 32(3 Suppl 1):4-14. PubMed ID: 12528069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COX-2-selective inhibitors in the treatment of arthritis.
    Schnitzer TJ; Hochberg MC
    Cleve Clin J Med; 2002; 69 Suppl 1():SI20-30. PubMed ID: 12086290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incremental cost-effectiveness analysis comparing rofecoxib with nonselective NSAIDs in osteoarthritis: Ontario Ministry of Health perspective.
    Marshall JK; Pellissier JM; Attard CL; Kong SX; Marentette MA
    Pharmacoeconomics; 2001; 19(10):1039-49. PubMed ID: 11735672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cost-effectiveness of cyclooxygenase-2 selective inhibitors in the management of chronic arthritis.
    Spiegel BM; Targownik L; Dulai GS; Gralnek IM
    Ann Intern Med; 2003 May; 138(10):795-806. PubMed ID: 12755551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meeting the therapeutic challenge of the patient with osteoarthritis.
    Todd C
    J Am Pharm Assoc (Wash); 2002; 42(1):74-82. PubMed ID: 11833521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What a difference a year makes: reflections on the ACR recommendations for the medical management of osteoarthritis.
    Hochberg MC
    Curr Rheumatol Rep; 2001 Dec; 3(6):473-8. PubMed ID: 11709108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines.
    Zhang W; Moskowitz RW; Nuki G; Abramson S; Altman RD; Arden N; Bierma-Zeinstra S; Brandt KD; Croft P; Doherty M; Dougados M; Hochberg M; Hunter DJ; Kwoh K; Lohmander LS; Tugwell P
    Osteoarthritis Cartilage; 2008 Feb; 16(2):137-62. PubMed ID: 18279766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COX-2 selective inhibitors: a literature review of analgesic efficacy and safety in oral-maxillofacial surgery.
    Cicconetti A; Bartoli A; Ripari F; Ripari A
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 Feb; 97(2):139-46. PubMed ID: 14970772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of analgesics in the management of osteoarthritis pain.
    Brandt KD
    Am J Ther; 2000 Mar; 7(2):75-90. PubMed ID: 11319576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathophysiology and first-line treatment of osteoarthritis.
    Hogue JH; Mersfelder TL
    Ann Pharmacother; 2002 Apr; 36(4):679-86. PubMed ID: 11918520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An evidence-based approach to prescribing nonsteroidal antiinflammatory drugs. Third Canadian Consensus Conference.
    Tannenbaum H; Bombardier C; Davis P; Russell AS;
    J Rheumatol; 2006 Jan; 33(1):140-57. PubMed ID: 16331802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of rofecoxib, celecoxib, and acetaminophen in osteoarthritis of the knee: a randomized trial.
    Geba GP; Weaver AL; Polis AB; Dixon ME; Schnitzer TJ;
    JAMA; 2002 Jan; 287(1):64-71. PubMed ID: 11754710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The promise of coxibs: how far have we progressed?
    Schumacher HR
    J Pain Symptom Manage; 2002 Apr; 23(4 Suppl):S1-4. PubMed ID: 11992742
    [No Abstract]   [Full Text] [Related]  

  • 17. Coxibs: Evolving role in pain management.
    Katz N
    Semin Arthritis Rheum; 2002 Dec; 32(3 Suppl 1):15-24. PubMed ID: 12528070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical pharmacology of selective COX-2 inhibitors.
    Capone ML; Tacconelli S; Sciulli MG; Patrignani P
    Int J Immunopathol Pharmacol; 2003; 16(2 Suppl):49-58. PubMed ID: 14552704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteoarthritis pain and its treatment.
    Creamer P
    Curr Opin Rheumatol; 2000 Sep; 12(5):450-5. PubMed ID: 10990186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of adverse renovascular experiences among osteoarthritis patients treated with rofecoxib and comparator non-selective non-steroidal anti-inflammatory agents.
    Gertz BJ; Krupa D; Bolognese JA; Sperling RS; Reicin A
    Curr Med Res Opin; 2002; 18(2):82-91. PubMed ID: 12017215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.